BASF Settles With US FTC About False Fatty Liver Claims For Hepaxa Omega-3 Supplements
German multi-national and a former US distributor agreed to pay more than $416,000 to US FTD for unsupported claims about omega-3 supplements for adults and children. In complaint, FTC alleged the firms “cherry picked” data from supporting human studies to fit claims.
You may also be interested in...
P&G plans up to double-digit price increases in US baby care, feminine care and adult incontinence and will analyze raw material costs and foreign exchange impacts in its other product categories for other pricing changes.
FTC files complaint against Quickwork as first action under authority granted in the COVID-19 Consumer Protection Act. The enforcement came after the firm twice ingored warnings to discontinue claims its vitamin D and zinc supplements were equal to or more effective than current vaccines.
Unilever’s Suave brand led new sanitizer product sales in 2020, when hand sanitizers total sales grew 569%, according to IRI. Sales of rinseable hand-soap sales grew 64% and antiseptics 19%.